| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2023 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.07M | 98.25M | 782.18M | 271.72M | 112.20M | 93.56M |
| Gross Profit | 16.76M | 28.18M | 59.51M | 37.63M | 19.38M | 18.61M |
| EBITDA | -103.47M | -129.58M | -1.38M | 3.12M | -27.94M | -4.21M |
| Net Income | -159.16M | -123.89M | 656.00K | 13.28M | -25.54M | 1.64M |
Balance Sheet | ||||||
| Total Assets | 508.06M | 538.01M | 727.93M | 593.42M | 369.22M | 360.00M |
| Cash, Cash Equivalents and Short-Term Investments | 21.69M | 30.53M | 6.31M | 8.48M | 27.59M | 17.66M |
| Total Debt | 173.88M | 171.97M | 124.11M | 137.96M | 26.94M | 34.74M |
| Total Liabilities | 341.85M | 344.97M | 432.62M | 283.06M | 174.56M | 155.53M |
| Stockholders Equity | 177.44M | 204.72M | 307.00M | 321.87M | 206.91M | 214.38M |
Cash Flow | ||||||
| Free Cash Flow | -28.20M | 45.92M | 11.80M | -222.47M | -25.67M | 1.22M |
| Operating Cash Flow | -28.01M | 46.11M | 12.58M | -217.05M | -25.13M | 1.61M |
| Investing Cash Flow | -10.63M | -95.33M | -146.00K | -764.00K | 1.03M | -6.09M |
| Financing Cash Flow | 7.45M | 62.45M | -14.40M | 200.86M | 33.98M | -2.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | HK$395.94M | -21.76 | -7.33% | ― | 11.32% | 62.61% | |
50 Neutral | HK$171.52M | 26.19 | 0.74% | ― | -9.32% | ― | |
49 Neutral | HK$261.45M | -0.28 | -30.56% | ― | 30.86% | -67.89% | |
48 Neutral | HK$290.33M | -2.06 | -66.52% | ― | -92.58% | -44916.67% | |
41 Neutral | HK$535.00M | -1.61 | -4.03% | ― | 55.27% | 68.84% |
Cherish Sunshine International has announced a series of board and management changes effective 19 March 2026, including the resignation of executive director and chief financial officer Sze Kam Shing Alan, who will remain as company secretary and an authorised representative. Independent non-executive director Deng Hua has also resigned from the board and its key committees to focus on other business commitments.
To fill the independent oversight gap, the company has appointed finance veteran Wang Xiaoqiong as an independent non-executive director and member of the nomination, remuneration and audit committees on a three-year term. With over 15 years of finance and accounting experience across listed companies and a current role in medical biotechnology, Wang’s appointment is expected to strengthen the group’s governance structure and ensure continuity in board committee functions despite the recent departures.
The most recent analyst rating on (HK:1094) stock is a Hold with a HK$0.41 price target. To see the full list of analyst forecasts on Cherish Sunshine International Limited stock, see the HK:1094 Stock Forecast page.
Cherish Sunshine International Limited has announced the composition of its board of directors, naming Yang Hua as executive director, joint chairman and chief executive, with Ng Siu Hong as non-executive director and three independent non-executive directors, Zhao Zhijiao, He Zhi and Wang Xiaoqiong, with Zhao also serving as joint chairman. The company also detailed the membership and chairmanship of its three key board committees, audit, remuneration and nomination, underscoring its corporate governance framework and the role of independent directors in overseeing financial reporting, pay and board appointments.
This latest board and committee lineup confirms the allocation of responsibilities among executive, non-executive and independent directors, which may enhance accountability and checks and balances within the organisation. By highlighting independent leadership of critical committees, Cherish Sunshine International signals continued adherence to governance norms expected of Hong Kong listed companies, which is relevant for investors monitoring oversight quality and board independence.
The most recent analyst rating on (HK:1094) stock is a Hold with a HK$0.41 price target. To see the full list of analyst forecasts on Cherish Sunshine International Limited stock, see the HK:1094 Stock Forecast page.
Cherish Sunshine International Limited has terminated a previously announced plan to form a joint venture with Xinhui Yuanheng to invest in the photovoltaic inverter business in mainland China. Although the JV company had been incorporated, neither party had injected share capital, and, following recent changes in PRC policies affecting the photovoltaic industry in early January 2026, both sides agreed that launching the venture was no longer commercially justifiable and signed a termination agreement on 16 January 2026, with the JV to be deregistered. The board stated that ending the venture is not expected to have a material adverse impact on the group’s financial performance or operations and considers the decision to be in the overall interests of the company and its shareholders.
The most recent analyst rating on (HK:1094) stock is a Hold with a HK$0.33 price target. To see the full list of analyst forecasts on Cherish Sunshine International Limited stock, see the HK:1094 Stock Forecast page.